Clinical Trials Directory

Trials / Unknown

UnknownNCT05421780

Post-prandial Glycaemic Controlling Effects of BSG in Singapore Adults With Metabolic Syndrome

Impact of Brewer's Spent Grain (BSG) and Bio-transformed BSG Biscuits on Post-prandial Glycaemic Controlling Effects in Singapore Adults With Metabolic Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
16 (actual)
Sponsor
National University of Singapore · Academic / Other
Sex
All
Age
35 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to assess the glycaemic controlling effects of BSG and bio-transformed BSG-containing biscuits in Singapore adults with MetS. The investigators hypothesized that consumption of BSG and bio-transformed BSG containing biscuit will improve glycaemic control.

Detailed description

This is a double-blind, randomised, crossover experiment. During the 3-week, 19 subjects will participate in a 3 meal tolerance test (MTT). During each MTT session, all subjects are required to consume 90 g biscuits (either control, autoclaved BSG or bio-transformed BSG biscuits) and monitored over a period of 240 minutes. All three types of biscuits will be consumed at a randomised sequence during this 3-week period. Post-prandial blood glucose, insulin, lipid and amino acid responses, breath analysis, body composition, blood pressure, appetite assessment, and any other glycaemic biomarkers will be assessed.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTautoclaved BSG-containing biscuitsConsumption of autoclaved BSG-containing biscuits as breakfast.
DIETARY_SUPPLEMENTbio-transformed BSG-containing biscuitsConsumption of bio-transformed BSG-containing biscuits as breakfast.
DIETARY_SUPPLEMENTcontrol biscuitsConsumption of plain biscuits as breakfast.

Timeline

Start date
2022-06-29
Primary completion
2022-12-13
Completion
2024-07-01
First posted
2022-06-16
Last updated
2023-11-09

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT05421780. Inclusion in this directory is not an endorsement.